Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Laparoscopic ovarian transposition prior to pelvic radiation for gynecologic cancer.

Swift BE, Leung E, Vicus D, Covens A.

Gynecol Oncol Rep. 2018 Apr 18;24:78-82. doi: 10.1016/j.gore.2018.04.005. eCollection 2018 May.

2.

Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?

Shah R, Xia C, Krailo M, Amatruda JF, Arul SG, Billmire DF, Brady WE, Covens A, Gershenson DM, Hale JP, Hurteau J, Murray MJ, Nicholson JC, Olson TA, Pashankar F, Rodriguez-Galindo C, Shaikh F, Stark D, Frazier AL, Stoneham S.

Gynecol Oncol. 2018 Aug;150(2):253-260. doi: 10.1016/j.ygyno.2018.05.025. Epub 2018 Jun 5.

PMID:
29884437
3.

Vulvar field resection: innovative procedure or same old?

Zigras T, Covens A.

Lancet Oncol. 2018 Apr;19(4):439-441. doi: 10.1016/S1470-2045(18)30110-4. Epub 2018 Mar 9. No abstract available.

PMID:
29530665
4.

Adolescents and Young Adults With a "Rare" Cancer: Getting Past Semantics to Optimal Care for Patients With Germ Cell Tumors.

Stoneham SJ, Hale JP, Rodriguez-Galindo C, Dang H, Olson T, Murray M, Amatruda JF, Thornton C, Arul GS, Billmire D, Krailo M, Stark D, Covens A, Hurteau J, Stenning S, Nicholson JC, Gershenson D, Frazier AL.

Oncologist. 2018 Feb;23(2):272. doi: 10.1634/theoncologist.2014-0009erratum. No abstract available.

5.

Ovarian Yolk Sac Tumors; Does Age Matter?

Faure Conter C, Xia C, Gershenson D, Hurteau J, Covens A, Pashankar F, Krailo M, Billmire D, Patte C, Fresneau B, Shaikh F, Stoneham S, Nicholson J, Murray M, Frazier AL.

Int J Gynecol Cancer. 2018 Jan;28(1):77-84. doi: 10.1097/IGC.0000000000001149.

PMID:
29194189
6.

Feasibility and safety of same-day discharge after laparoscopic radical hysterectomy for cervix cancer.

Philp L, Covens A, Vicus D, Kupets R, Pulman K, Gien LT.

Gynecol Oncol. 2017 Dec;147(3):572-576. doi: 10.1016/j.ygyno.2017.09.026. Epub 2017 Sep 29.

PMID:
28965697
7.

Development of a comprehensive and sustainable gynecologic oncology training program in western Kenya, a low resource setting.

Rosen B, Itsura P, Tonui P, Covens A, van Lonkhuijzen L, Orang'o EO.

Gynecol Oncol Rep. 2017 Jul 20;21:122-127. doi: 10.1016/j.gore.2017.06.014. eCollection 2017 Aug.

8.

Is adjuvant chemotherapy beneficial for surgical stage I ovarian clear cell carcinoma?

Hogen L, Brar H, Covens A, Bassiouny D, Bernardini MQ, Gien LT, Ferguson SE, Vicus D.

Gynecol Oncol. 2017 Oct;147(1):54-60. doi: 10.1016/j.ygyno.2017.07.128. Epub 2017 Jul 29.

PMID:
28760368
9.

Implementing a Cervical Sentinel Lymph Node Biopsy Program: Quality Improvement in Gynaecologic Oncology.

Cusimano MC, Walker R, Bernardini MQ, Bouchard-Fortier G, Laframboise S, May T, Murphy J, Rosen B, Covens A, Clarke B, Shaw P, Rouzbahman M, Mohan R, Ferguson SE.

J Obstet Gynaecol Can. 2017 Aug;39(8):659-667. doi: 10.1016/j.jogc.2017.02.017.

PMID:
28729099
10.

Early Cervical Cancer: Current Dilemmas of Staging and Surgery.

Zigras T, Lennox G, Willows K, Covens A.

Curr Oncol Rep. 2017 Aug;19(8):51. doi: 10.1007/s11912-017-0614-5. Review.

PMID:
28664470
11.

Management Of Early Stage Cervical Cancer: When Is Non-Randomized Data Good Enough?

Lennox GK, Covens A.

Gynecol Oncol. 2017 Jul;146(1):1-2. doi: 10.1016/j.ygyno.2017.06.006. No abstract available.

PMID:
28625331
12.

Cost-effectiveness of sentinel node biopsy and pathological ultrastaging in patients with early-stage cervical cancer.

Brar H, Hogen L, Covens A.

Cancer. 2017 May 15;123(10):1751-1759. doi: 10.1002/cncr.30509. Epub 2017 Jan 24.

13.

Does a groin node dissection in vulvar cancer affect groin recurrence and overall survival?: Results from a population-based cohort study.

Gien LT, Sutradhar R, Thomas G, Covens A, Elit L, Rakovitch E, Fyles A, Khalifa MA, Liu Y, Barbera L.

Gynecol Oncol. 2017 Feb;144(2):318-323. doi: 10.1016/j.ygyno.2016.11.026. Epub 2016 Nov 16.

PMID:
27865454
14.

Fertility-sparing management in cervical cancer: balancing oncologic outcomes with reproductive success.

Willows K, Lennox G, Covens A.

Gynecol Oncol Res Pract. 2016 Oct 21;3:9. eCollection 2016. Review.

15.

Cervix Cancer Research Network (CCRN): Improving Access to Cervix Cancer Trials on a Global Scale.

Gaffney D, Small B, Kitchener H, Young Ryu S, Viswanathan A, Trimble T, Covens A, Wilailak S, Lertkhachonsuk AA, Sitathanee C, Mahantshetty U, Fisher B, Springer S, Pollatz T, Spiller A, Bacon M, Jhingran A.

Int J Gynecol Cancer. 2016 Nov;26(9):1690-1693.

PMID:
27779548
16.

Can sentinel lymph node biopsy replace pelvic lymphadenectomy for early cervical cancer?

Lennox GK, Covens A.

Gynecol Oncol. 2017 Jan;144(1):16-20. doi: 10.1016/j.ygyno.2016.08.337. Epub 2016 Oct 11.

PMID:
27742472
17.

The Added Value of Pathology Review in Vulvar Cancer: Results From a Population-based Cohort Study.

Barbera L, Gien LT, Sutradhar R, Thomas G, Covens A, Elit L, Fyles A, Rakovitch E, Liu Y, Khalifa M.

Int J Gynecol Pathol. 2017 Mar;36(2):107-110. doi: 10.1097/PGP.0000000000000313.

PMID:
27513080
18.

Sister Society Meeting on Global Education Development and Collaboration: Meeting Report.

Chuang LT, Randall TC, Denny L, Johnston CM, Schmeler KM, Covens AL, Cibula D, Bookman MA, Rawal S, DePetrillo D, Nam JH, Goodman A, Naik R, Manchanda R, Gaffney DK, Small W Jr, Creutzberg C, Rattray C, Kesic V, Paraja R, Eiken M, Belleson K, Coleman RL, Barakat RR, Trimble EL, Quinn M.

Int J Gynecol Cancer. 2016 Jul;26(6):1186-8. doi: 10.1097/IGC.0000000000000735.

PMID:
27327155
19.

Cost-Efficiency of Robotic Surgery.

Covens A, Köhler C, Nam JH, Naumann RW, Obermair A, Querleu D.

Int J Gynecol Cancer. 2016 Jul;26(6):992-3. doi: 10.1097/IGC.0000000000000747. No abstract available.

PMID:
27327148
20.

How Common Is the Growing Teratoma Syndrome in Patients With Ovarian Immature Teratoma?

Van Nguyen JM, Bouchard-Fortier G, Ferguson SE, Covens A.

Int J Gynecol Cancer. 2016 Sep;26(7):1201-6. doi: 10.1097/IGC.0000000000000751.

PMID:
27258729
21.

Surgical Stage I high-grade ovarian cancer: is adjuvant chemotherapy warranted?

Segev Y, Ismiil N, McVey R, Covens A.

Eur J Gynaecol Oncol. 2015;36(6):633-6.

PMID:
26775342
22.

A comparison of the toxicity and tolerability of two intraperitoneal chemotherapy regimens for advanced-stage epithelial ovarian cancer.

Bouchard-Fortier G, Rosen B, Vyarvelska I, Pasetka M, Covens A, Gien LT, Kupets R, Pulman K, Ferguson SE, Vicus D.

Gynecol Oncol. 2016 Jan;140(1):36-41. doi: 10.1016/j.ygyno.2015.11.005. Epub 2015 Nov 4.

PMID:
26546964
23.

Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative.

Pashankar F, Hale JP, Dang H, Krailo M, Brady WE, Rodriguez-Galindo C, Nicholson JC, Murray MJ, Bilmire DF, Stoneham S, Arul GS, Olson TA, Stark D, Shaikh F, Amatruda JF, Covens A, Gershenson DM, Frazier AL.

Cancer. 2016 Jan 15;122(2):230-7. doi: 10.1002/cncr.29732. Epub 2015 Oct 20. Erratum in: Cancer. 2018 Mar 15;124(6):1302.

24.

Patient, tumor, and health system factors affecting groin node dissection rates in vulvar carcinoma: A population-based cohort study.

Gien LT, Sutradhar R, Thomas G, Covens A, Elit L, Rakovitch E, Fyles A, Khalifa MA, Liu Y, Barbera L.

Gynecol Oncol. 2015 Dec;139(3):465-70. doi: 10.1016/j.ygyno.2015.09.086. Epub 2015 Oct 23.

PMID:
26483007
25.

Who should be offered non-radical surgery for early-stage cervical cancer?

Bouchard-Fortier G, Covens A.

J Gynecol Oncol. 2015 Oct;26(4):243-5. doi: 10.3802/jgo.2015.26.4.243. Epub 2015 Oct 12. No abstract available.

26.

Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to Collaboration.

Olson TA, Murray MJ, Rodriguez-Galindo C, Nicholson JC, Billmire DF, Krailo MD, Dang HM, Amatruda JF, Thornton CM, Arul GS, Stoneham SJ, Pashankar F, Stark D, Shaikh F, Gershenson DM, Covens A, Hurteau J, Stenning SP, Feldman DR, Grimison PS, Huddart RA, Sweeney C, Powles T, Lopes LF, dos Santos Agular S, Chinnaswamy G, Khaleel S, Abouelnaga S, Hale JP, Frazier AL.

J Clin Oncol. 2015 Sep 20;33(27):3018-28. doi: 10.1200/JCO.2014.60.5337. Epub 2015 Aug 24. Review. Erratum in: J Clin Oncol. 2015 Nov 20;33(33):3981.

27.

Trends in cervical intraepithelial neoplasia Grade 2+ after human papillomavirus vaccination: The devil is in the details.

Brar H, Covens A.

Cancer. 2015 Aug 15;121(16):2674-7. doi: 10.1002/cncr.29264. Epub 2015 Jun 22. No abstract available.

28.

Sentinel lymph node biopsy in vulvar cancer: Systematic review, meta-analysis and guideline recommendations.

Covens A, Vella ET, Kennedy EB, Reade CJ, Jimenez W, Le T.

Gynecol Oncol. 2015 May;137(2):351-61. doi: 10.1016/j.ygyno.2015.02.014. Epub 2015 Feb 20. Review.

PMID:
25703673
29.

Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the uterine corpus and cervix.

Hasegawa K, Nagao S, Yasuda M, Millan D, Viswanathan AN, Glasspool RM, Devouassoux-Shisheboran M, Covens A, Lorusso D, Kurzeder C, Kim JW, Gladieff L, Bryce J, Friedlander M, Fujiwara K.

Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S90-5. doi: 10.1097/IGC.0000000000000297. Review.

PMID:
25341588
30.

Gynecologic Cancer InterGroup (GCIG) consensus review for mullerian adenosarcoma of the female genital tract.

Friedlander ML, Covens A, Glasspool RM, Hilpert F, Kristensen G, Kwon S, Selle F, Small W, Witteveen E, Russell P.

Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S78-82. doi: 10.1097/IGC.0000000000000239. Review.

PMID:
25341585
31.

Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary.

Okamoto A, Glasspool RM, Mabuchi S, Matsumura N, Nomura H, Itamochi H, Takano M, Takano T, Susumu N, Aoki D, Konishi I, Covens A, Ledermann J, Mezzanzanica D, Steer C, Millan D, McNeish IA, Pfisterer J, Kang S, Gladieff L, Bryce J, Oza A.

Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S20-5. doi: 10.1097/IGC.0000000000000289. Review. Erratum in: Int J Gynecol Cancer. 2015 May;25(4):721. Mezzazanica, Delia [corrected to Mezzanzanica, Delia].

PMID:
25341576
32.

Determining the role of a national objective assessment of surgical skills in gynecological oncology: an e-Delphi methodology.

McVey RM, Clarke E, Segev Y, Grantcharov T, Covens A.

Int J Gynecol Cancer. 2014 Jul;24(6):1098-104. doi: 10.1097/IGC.0000000000000157.

PMID:
24978713
33.

Adolescents and young adults with a "rare" cancer: getting past semantics to optimal care for patients with germ cell tumors.

Stoneham SJ, Hale JP, Rodriguez-Galindo C, Dang H, Olson T, Murray M, Amatruda JF, Thornton C, Arul GS, Billmire D, Krailo M, Stark D, Covens A, Hurteau J, Stenning S, Nicholson JC, Gershenson D, Frazier AL.

Oncologist. 2014 Jul;19(7):689-92. doi: 10.1634/theoncologist.2014-0009. Epub 2014 Jun 4. No abstract available. Erratum in: Oncologist. 2018 Feb;23 (2):272.

34.

Is venous thromboprophylaxis necessary in patients undergoing minimally invasive surgery for a gynecologic malignancy?

Bouchard-Fortier G, Geerts WH, Covens A, Vicus D, Kupets R, Gien LT.

Gynecol Oncol. 2014 Aug;134(2):228-32. doi: 10.1016/j.ygyno.2014.05.012. Epub 2014 May 27.

PMID:
24875122
35.

State of the science in cervical cancer: where we are today and where we need to go.

Dizon DS, Mackay HJ, Thomas GM, Werner TL, Kohn EC, Hess D, Rose PG, Covens AL.

Cancer. 2014 Aug 1;120(15):2282-8. doi: 10.1002/cncr.28722. Epub 2014 Apr 15. Review.

36.

Non-radical surgery for small early-stage cervical cancer. Is it time?

Bouchard-Fortier G, Reade CJ, Covens A.

Gynecol Oncol. 2014 Mar;132(3):624-7. doi: 10.1016/j.ygyno.2014.01.037. Epub 2014 Jan 27.

PMID:
24480237
37.

Assessment of endometrial sampling as a predictor of final surgical pathology in endometrial cancer.

Helpman L, Kupets R, Covens A, Saad RS, Khalifa MA, Ismiil N, Ghorab Z, Dubé V, Nofech-Mozes S.

Br J Cancer. 2014 Feb 4;110(3):609-15. doi: 10.1038/bjc.2013.766. Epub 2013 Dec 24.

38.

Surgery for early stage cervical cancer: how radical should it be?

Reade CJ, Eiriksson LR, Covens A.

Gynecol Oncol. 2013 Oct;131(1):222-30. doi: 10.1016/j.ygyno.2013.07.078. Epub 2013 Jul 14. Review.

PMID:
23863357
39.

Is routine appendectomy at the time of primary surgery for mucinous ovarian neoplasms beneficial?

Feigenberg T, Covens A, Ghorab Z, Ismiil N, Dubé V, Saad RS, Khalifa MA, Nofech-Mozes S.

Int J Gynecol Cancer. 2013 Sep;23(7):1205-9. doi: 10.1097/IGC.0b013e31829b7dca.

PMID:
23835504
40.

Sentinel lymph node biopsy in vulvar cancer: a health technology assessment for the canadian health care context.

Reade CJ, Jimenez W, O'Reilly D, Covens A.

J Obstet Gynaecol Can. 2012 Nov;34(11):1053-1065. doi: 10.1016/S1701-2163(16)35435-4. Review.

PMID:
23231843
41.

Vaginal vault dehiscence and increased use of vaginal vault brachytherapy: what are the implications?

Wiebe E, Covens A, Thomas G.

Int J Gynecol Cancer. 2012 Nov;22(9):1611-6. doi: 10.1097/IGC.0b013e31826fd490. Review.

PMID:
23095777
42.

Management of a suspicious adnexal mass: a clinical practice guideline.

Dodge JE, Covens AL, Lacchetti C, Elit LM, Le T, Devries-Aboud M, Fung-Kee-Fung M; Gynecology Cancer Disease Site Group.

Curr Oncol. 2012 Aug;19(4):e244-57. doi: 10.3747/co.19.980.

43.

Advancing fertility-sparing treatments in cervical cancer: where is the limit?

Eiriksson L, Covens A.

Gynecol Oncol. 2012 Sep;126(3):317-8. doi: 10.1016/j.ygyno.2012.07.093. No abstract available.

PMID:
22840441
44.

Surgical management of a suspicious adnexal mass: a systematic review.

Covens AL, Dodge JE, Lacchetti C, Elit LM, Le T, Devries-Aboud M, Fung-Kee-Fung M; Gynecology Cancer Disease Site Group.

Gynecol Oncol. 2012 Jul;126(1):149-56. doi: 10.1016/j.ygyno.2012.04.018. Epub 2012 Apr 19. Review.

PMID:
22522189
45.

Preoperative identification of a suspicious adnexal mass: a systematic review and meta-analysis.

Dodge JE, Covens AL, Lacchetti C, Elit LM, Le T, Devries-Aboud M, Fung-Kee-Fung M; Gynecology Cancer Disease Site Group.

Gynecol Oncol. 2012 Jul;126(1):157-66. doi: 10.1016/j.ygyno.2012.03.048. Epub 2012 Apr 6. Review.

PMID:
22484399
46.

Randomized, double-blind, placebo-controlled phase II study of AMG 386 combined with weekly paclitaxel in patients with recurrent ovarian cancer.

Karlan BY, Oza AM, Richardson GE, Provencher DM, Hansen VL, Buck M, Chambers SK, Ghatage P, Pippitt CH Jr, Brown JV 3rd, Covens A, Nagarkar RV, Davy M, Leath CA 3rd, Nguyen H, Stepan DE, Weinreich DM, Tassoudji M, Sun YN, Vergote IB.

J Clin Oncol. 2012 Feb 1;30(4):362-71. doi: 10.1200/JCO.2010.34.3178. Epub 2011 Dec 19.

PMID:
22184370
47.

Progression-free survival in advanced ovarian cancer: a Canadian review and expert panel perspective.

Oza AM, Castonguay V, Tsoref D, Diaz-Padilla I, Karakasis K, Mackay H, Welch S, Weberpals J, Hoskins P, Plante M, Provencher D, Tonkin K, Covens A, Ghatage P, Gregoire J, Hirte H, Miller D, Rosen B, Maroun J, Buyse M, Coens C, Brady MF, Stuart GC.

Curr Oncol. 2011 Oct;18 Suppl 2:S20-7.

48.

Sentinel lymph node mapping in cervical cancer: the future?

Eiriksson LR, Covens A.

BJOG. 2012 Jan;119(2):129-33. doi: 10.1111/j.1471-0528.2011.03134.x. Epub 2011 Sep 14. No abstract available.

49.

Early adenocarcinoma of the cervix: is radical vaginal trachelectomy safe?

Helpman L, Grisaru D, Covens A.

Gynecol Oncol. 2011 Oct;123(1):95-8. doi: 10.1016/j.ygyno.2011.06.024. Epub 2011 Jul 20.

PMID:
21774971
50.

Follow-up after chemoradiation for cervical cancer: Why?

Eiriksson LR, Covens A.

Cancer. 2011 Sep 1;117(17):3875-8. doi: 10.1002/cncr.25990. Epub 2011 Mar 8. No abstract available.

Supplemental Content

Loading ...
Support Center